Background The consequences of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) on cardiovascular (CV) risk in hypertensive patients with type 2 diabetes mellitus (T2 DM) are uncertain. ramifications of ACE/ARBs treatment in hypertensive sufferers with T2 DM. Outcomes Ten randomized managed studies had been included with a complete of 21,871 individuals. General,… Continue reading Background The consequences of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II